每年專案
個人檔案
學歷
- 2002-2007 Postdoctoral training in Hematology and Oncology, Mount Sinai School of Medicine, New York, USA
- 1997.09-2002.05 美國紐約市立大學Biology博士
- 1994.09-1997.07 美國紐約市立大學Biology碩士
- 1984.09-1988.06 國立中興大學植物病理學系學士
經歷
- 2018.02- 臺北醫學大學國際醫學研究碩士學位學程副教授
- 2018.02- 臺北醫學大學細胞治療與再生醫學國際博士學位副教授
- 2016.11-2017.10 臺北醫學大學國際醫學研究碩士學位學程副教授
- 2013.02- 臺北醫學大學醫學科學研究所副教授
- 2009.08-2013.07 臺北醫學大學醫學科學研究所助理教授
- 2009.02-2009.07 中山醫學大學微生物免疫研究所助理教授
- 2007.10-2008.10 Research Associate, Hematology and Oncology/Medicine, Mount Sinai School of Medicine, New York, USA
- 1994-2008 Postdoctoral Fellow, Hematology and Oncology/Medicine, Mount Sinai School of Medicine, New York, USA
- 1994-2001 Adjunct Lecturer, Biology, Queens College, City University of New York
獎項
- 2007 Travel Award, ASH 50th Annual Meeting, San Diego, CA
研究興趣
- Leukocyte trafficking, Cancer biology, Wound healing, Traumatic brain injury
指紋
查看啟用 Jungshan Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
專案
- 16 已完成
-
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估-α9尼古丁受體於小鼠模式探討致癌機制與奈米藥物之臨床前試驗評估(3/3)
8/1/19 → 7/31/20
研究計畫: A - 政府部門 › b - 科技部
-
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估-α9尼古丁受體於小鼠模式探討致癌機制與奈米藥物之臨床前試驗評估(2/3)
8/1/18 → 8/1/19
研究計畫: A - 政府部門 › b - 科技部
-
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估-α9尼古丁受體於小鼠模式探討致癌機制與奈米藥物之臨床前試驗評估(1/3)
8/1/17 → 7/31/18
研究計畫: A - 政府部門 › b - 科技部
-
-
-
Radiotherapy enhances CXCR3highCD8+ T cell activation through inducing IFNγ-mediated CXCL10 and ICAM-1 expression in lung cancer cells
Wang, C. L., Ho, A. S., Chang, C. C., Sie, Z. L., Peng, C. L., Chang, J. & Cheng, C. C., 2023, (接受/付印) 於: Cancer Immunology, Immunotherapy.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Airway Exposure to 1,3-Beta-d-Glucan Induces Airway Hyperresponsiveness in Guinea Pigs
Lin, Y. S., Chen, Y. Y., Chan, N. J., Chang, J., Li, S. S. & Hsu, C. C., 3月 11 2022, 於: ACS Pharmacology and Translational Science. 5, 3, p. 169-175 7 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Caffeic Acid Phenethyl Ester Inhibits Basal Lipolysis by Activating PPAR-Gamma and Increasing Lipid Droplet-Associated Perilipin in Mature Rat Adipocytes
Trang, N. T. T., Chiu, W. C., Feng, Y. T., Hsieh, S. L., Tung, D. D., Chang, J. & Fong, T. H., 2022, 於: Evidence-based Complementary and Alternative Medicine. 2022, 6007233.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Combined impacts of histamine receptor H1 gene polymorphisms and an environmental carcinogen on the susceptibility to and progression of oral squamous cell carcinoma
Ding, Y. F., Lin, Y. W., Chiu, W. K., Lin, C. W., Yang, Y. C., Chang, L. C., Chang, J., Yang, S. F. & Chien, M. H., 2022, 於: Aging. 14, 10, p. 4500-4512 13 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Improving Tirapazamine (TPZ) to Target and Eradicate Hypoxia Tumors by Gold Nanoparticle Carriers
Ajnai, G., Cheng, C. C., Kan, T. C., Lu, J. W., Rahayu, S., Chiu, A. & Chang, J., 4月 2022, 於: Pharmaceutics. 14, 4, 847.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取2 引文 斯高帕斯（Scopus）
資料集
-
MOESM11 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Ho, A. (Contributor), Cheng, C. (Contributor), Chang, J. (Creator), Chang, Y. (Creator), Chiang, Y. (Creator), Sie, Z. (Creator) & Lim, K. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.9993542.v1, https://doi.org/10.6084%2Fm9.figshare.9993542.v1
資料集: Dataset
-
CCDC 1517710: Experimental Crystal Structure Determination
Lu, N. (Creator), Alagesan, M. (Creator), Ho, C. (Creator), Wei, R. (Creator), Kung, C. (Creator), Chang, J. (Creator), Wen, Y. (Creator) & Liu, L. (Creator), Cambridge Crystallographic Data Centre, 2016
DOI: 10.5517/ccdc.csd.cc1my9d8, http://www.ccdc.cam.ac.uk/services/structure_request%3Fid=doi:10.5517/ccdc.csd.cc1my9d8&sid=DataCite
資料集: Dataset
-
MOESM2 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Sie, Z. (Creator), Chiang, Y. (Creator), Chang, Y. (Creator), Ho, A. (Contributor), Cheng, C. (Contributor), Chang, J. (Creator) & Lim, K. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.9993560.v1, https://doi.org/10.6084%2Fm9.figshare.9993560.v1
資料集: Dataset
-
MOESM3 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Lim, K. (Contributor), Chiang, Y. (Creator), Chang, J. (Creator), Ho, A. (Contributor), Sie, Z. (Creator), Chang, Y. (Creator) & Cheng, C. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.9993563.v1, https://doi.org/10.6084%2Fm9.figshare.9993563.v1
資料集: Dataset
-
MOESM5 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Ho, A. (Contributor), Chiang, Y. (Creator), Chang, Y. (Creator), Chang, J. (Creator), Lim, K. (Contributor), Sie, Z. (Creator) & Cheng, C. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.9993575.v1, https://doi.org/10.6084%2Fm9.figshare.9993575.v1
資料集: Dataset